Loading stock data…
Loading stock data…
US$0.74
Get one email when CALC crosses your level. Checked every 15 minutes during market hours.
▲ +0.04 (5.99%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
44.8
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.01
Bearish momentumMACD below its signal line (0.02).
50-day average
0.80
Price belowShort-term trend reference.
200-day average
2.16
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Calcimedica Inc. is a biopharmaceutical company focused on developing new therapies that target calcium-release-activated calcium (CRAC) channels. These channels play a crucial role in calcium-mediated signaling in cells, essential for the body's immune response. Calcimedica's primary objective is to innovate treatments for inflammatory diseases such as acute pancreatitis and acute lung injuries, where these channels have shown significant therapeutic potential. The company's research and develo…
calcimedica.com3 strong buy · 5 buy · 2 hold · 0 sell · 0 strong sell (10 analysts, 2026-07-01)
3 strong buy · 5 buy · 2 hold · 0 sell · 0 strong sell (10 analysts, 2026-06-01)
3 strong buy · 5 buy · 2 hold · 0 sell · 0 strong sell (10 analysts, 2026-05-01)
3 strong buy · 5 buy · 2 hold · 0 sell · 0 strong sell (10 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-06 | 2.55 | 2.72 | ✓ Beat |
| 2026-03-03 | -0.41 | -0.69 | ✗ Miss |
| 2026-01-27 | 2.2 | 2.38 | ✓ Beat |
| 2026-01-17 | 0.38 | 0.34 | ✗ Miss |
| 2025-11-12 | -0.41 | -0.52 | ✗ Miss |
| 2025-08-12 | -0.35 | -0.4 | ✗ Miss |
| 2025-05-14 | -0.3 | -0.36 | ✗ Miss |
Companies in the same industry, via Finnhub